Daniel Garbin Di Luca

Dr. Daniel Garbin Di Luca is driving progress in the field of neurology as an Assistant Professor at Washington University School of Medicine. With a specialization in adult neurology and movement disorders, Dr. Di Luca is at the forefront of research and clinical practice in conditions such as Parkinson's Disease, parkinsonism, and deep brain stimulation. His comprehensive expertise extends to managing tremor, essential tremor, dystonia, Huntington's disease, ataxia, Multiple System Atrophy, and Progressive Supranuclear Palsy. Fluent in English, Portuguese, and Spanish, Dr. Di Luca brings a multicultural perspective to his practice, enhancing his ability to communicate effectively with a diverse patient population. His board certification in Neurology from the American Board of Psychiatry and Neurology underscores his commitment to maintaining the highest standards of clinical excellence. Dr. Di Luca's research interests are deeply rooted in the exploration of neuromodulation and epidemiology. He is particularly focused on developing novel therapies aimed at alleviating both motor and non-motor symptoms associated with Parkinson's Disease and other movement disorders. His work is pivotal in advancing our understanding of these complex conditions and improving patient outcomes. At Washington University, Dr. Di Luca is involved in both teaching and mentoring, guiding the next generation of neurologists in the intricacies of movement disorders. His dedication to education is matched by his passion for research, where he continually seeks to bridge the gap between clinical practice and scientific discovery. In addition to his academic and clinical roles, Dr. Di Luca is an active participant in various professional organizations, contributing to the broader neurological community. His collaborative approach and innovative thinking make him a valuable asset to both his institution and the field of neurology at large. Through his work, Dr. Di Luca is not only advancing the understanding of movement disorders but also paving the way for new treatment paradigms that promise to enhance the quality of life for patients worldwide. His contributions are a testament to his unwavering dedication to the field of neurology and his commitment to making a meaningful impact on the lives of those affected by these challenging conditions.